1. Leahy DE (2004) Drug discovery information integration: virtual humans for pharmacokinetics. Biosilico 2:78–84
2. Lin J, Sahakian DC, de Morais SM, Xu JJ, Polzer RJ, Winter SM (2003) The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery. Curr Top Med Chem 3:1125–1154
3. van de Waterbeemd H, Gifford E (2003) ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2:192–204
4. Peters SA, Ungell AL, Dolgos H (2009) Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization. Curr Opin Drug Discov Devel 12:509–518
5. EPA. US (2006) Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment (Final report). EPA/600/R-05/043F